Viridian Therapeutics, Inc. (VRDN) Tops Q1 EPS by 99c

Viridian Therapeutics, Inc. (NASDAQ: VRDN) reported Q1 EPS of ($0.09), $0.99 better than the analyst estimate of ($1.08). Revenue for the quarter came in at $140 thousand versus the consensus estimate of $33.31 thousand.

For earnings history and earnings-related data on Viridian Therapeutics, Inc. (VRDN) click here.

You May Also Be Interested In

• Movano (MOVE) Misses Q2 EPS by 195c
• Home Depot (HD) call put ratio 1.5 calls to 1 put with a focus on September 330 puts into quarter results
• Zeo Energy Corp (ZEO) Misses Q2 EPS by 7c